<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347837</url>
  </required_header>
  <id_info>
    <org_study_id>CP-2019-01</org_study_id>
    <nct_id>NCT04347837</nct_id>
  </id_info>
  <brief_title>Multisite Study of Titan SGS Stapler in Longitudinal Gastric Resection</brief_title>
  <official_title>Multisite Study of Titan SGS Stapler in Longitudinal Gastric Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Standard Bariatrics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Standard Bariatrics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Titan SGS stapler is the first minimally invasive stapler designed for the longitudinal
      resection of the stomach. This is the first experience using this stapler in humans. The
      purpose of this study is to demonstrate use of the Titan SGS stapler in creating longitudinal
      gastric resection. Safety is defined by the absence of device related adverse events in the
      study period. Usability is evaluated based on surgeon evaluation of the device following each
      use.

      This is a open label clinical trial to be conducted at three US sites. Up to 60 participants
      will be enrolled and will be followed for 6 weeks after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of the Titan SGS stapler</measure>
    <time_frame>6 weeks</time_frame>
    <description>• Safety will be defined using descriptive statistics for device related adverse events in the study period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Usability</measure>
    <time_frame>1 day</time_frame>
    <description>• Usability of the Titan SGS to resect the stomach will be determined by the intraoperative assessment of the surgeon. The surgeon will complete a questionnaire with assessments of the device.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Investigational device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigational device will be used for all participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Titan SGS stapler</intervention_name>
    <description>Stapler for the longitudinal resection of the stomach</description>
    <arm_group_label>Investigational device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Patients age 18 to 65 undergoing a procedure requiring longitudinal gastric resection
        including: laparoscopic sleeve gastrectomy, laparoscopic gastric wedge resection,
        laparoscopic duodenal switch/loop duodenal switch.

        Exclusion Criteria:

          1. Age &lt; 18 years

          2. Incarceration

          3. Prior gastric or foregut surgery (hiatal hernia repair, lap band +/- removal, Nissen
             fundoplication, gastrostomy tube, greater curve plication, sleeve gastrectomy etc.)

          4. Diagnosed bleeding disorder (hyper or hypocoagulable state)

          5. Systemic anticoagulation

          6. Significant organ system disease

               1. Stage III CKD or greater

               2. Liver cirrhosis (any)

               3. CHG with EF &lt; 50%

               4. COPD with O2 dependence

               5. Uncontrolled diabetes mellitus (A1C &gt; 10%)

          7. Intraoperative surgeon evaluation indicates the subject is not a candidate for
             longitudinal gastric resection with the Titan Stapler due to anatomic factors such as
             extensive abdominal adhesions or the device will not fit for the particular
             application.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kaleida Health Buffalo General Hospital</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Aaron Hoffman, MD</last_name>
      <phone>716-859-5600</phone>
      <email>abh2@buffalo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>WakeMed Bariatric Specialists of North Carolina</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27511</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Paul Enochs, MD</last_name>
      <phone>919-234-4468</phone>
      <email>penochs@wakemed.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Chester Hospital</name>
      <address>
        <city>West Chester</city>
        <state>Ohio</state>
        <zip>45069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 13, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

